DDX11-AS1 may promote the EMT process via sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and enhance the activity of Wnt/β-catenin pathway, which further affects the malignant progression of ESCC patients. The gene discussed is ZEB2; the disease is esophageal squamous cell carcinoma.